Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice
Diets rich in polyphenols are known to be beneficial for cardiovascular health. Gallic acid (GA) is a plant-derived triphenolic chemical with multiple cardio-protective properties, such as antiobesity, anti-inflammation, and antioxidation. However, whether GA could protect against atherosclerotic ca...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2022/7909971 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832553699730259968 |
---|---|
author | Jie Bai Qiu-Yue Lin Xiangbo An Shuang Liu Yao Wang Yunpeng Xie Jiawei Liao |
author_facet | Jie Bai Qiu-Yue Lin Xiangbo An Shuang Liu Yao Wang Yunpeng Xie Jiawei Liao |
author_sort | Jie Bai |
collection | DOAJ |
description | Diets rich in polyphenols are known to be beneficial for cardiovascular health. Gallic acid (GA) is a plant-derived triphenolic chemical with multiple cardio-protective properties, such as antiobesity, anti-inflammation, and antioxidation. However, whether GA could protect against atherosclerotic cardiovascular diseases is still not defined. Here, we investigated the effects of low-dose GA administration on diet-induced metabolic disorders and atherosclerosis in the atherosclerosis-prone apolipoprotein E (Apoe) knockout mice fed on a high-fat Western-type diet (WTD) for 8 weeks. Our data showed that GA administration by oral gavage at a daily dosage of 20 mg/kg body weight did not significantly ameliorate WTD-induced hyperlipidemia, hepatosteatosis, adipogenesis, or insulin resistance; furthermore, GA administration did not significantly ameliorate WTD-induced atherosclerosis. In conclusion, our data demonstrate that low-dose GA administration does not elicit significant health effect on diet-induced metabolic disorders or atherosclerosis in the Apoe knockout mice. Whether GA could be beneficial for atherosclerotic cardiovascular diseases therefore needs further exploration. |
format | Article |
id | doaj-art-9d2d9aa383644501a54d027ff1781003 |
institution | Kabale University |
issn | 2314-7156 |
language | English |
publishDate | 2022-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Immunology Research |
spelling | doaj-art-9d2d9aa383644501a54d027ff17810032025-02-03T05:53:27ZengWileyJournal of Immunology Research2314-71562022-01-01202210.1155/2022/7909971Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout MiceJie Bai0Qiu-Yue Lin1Xiangbo An2Shuang Liu3Yao Wang4Yunpeng Xie5Jiawei Liao6Institute of Cardiovascular DiseasesInstitute of Cardiovascular DiseasesDepartment of Interventional TherapyCollege of Basic Medical SciencesInstitute of Cardiovascular DiseasesInstitute of Cardiovascular DiseasesInstitute of Cardiovascular DiseasesDiets rich in polyphenols are known to be beneficial for cardiovascular health. Gallic acid (GA) is a plant-derived triphenolic chemical with multiple cardio-protective properties, such as antiobesity, anti-inflammation, and antioxidation. However, whether GA could protect against atherosclerotic cardiovascular diseases is still not defined. Here, we investigated the effects of low-dose GA administration on diet-induced metabolic disorders and atherosclerosis in the atherosclerosis-prone apolipoprotein E (Apoe) knockout mice fed on a high-fat Western-type diet (WTD) for 8 weeks. Our data showed that GA administration by oral gavage at a daily dosage of 20 mg/kg body weight did not significantly ameliorate WTD-induced hyperlipidemia, hepatosteatosis, adipogenesis, or insulin resistance; furthermore, GA administration did not significantly ameliorate WTD-induced atherosclerosis. In conclusion, our data demonstrate that low-dose GA administration does not elicit significant health effect on diet-induced metabolic disorders or atherosclerosis in the Apoe knockout mice. Whether GA could be beneficial for atherosclerotic cardiovascular diseases therefore needs further exploration.http://dx.doi.org/10.1155/2022/7909971 |
spellingShingle | Jie Bai Qiu-Yue Lin Xiangbo An Shuang Liu Yao Wang Yunpeng Xie Jiawei Liao Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice Journal of Immunology Research |
title | Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice |
title_full | Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice |
title_fullStr | Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice |
title_full_unstemmed | Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice |
title_short | Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice |
title_sort | low dose gallic acid administration does not improve diet induced metabolic disorders and atherosclerosis in apoe knockout mice |
url | http://dx.doi.org/10.1155/2022/7909971 |
work_keys_str_mv | AT jiebai lowdosegallicacidadministrationdoesnotimprovedietinducedmetabolicdisordersandatherosclerosisinapoeknockoutmice AT qiuyuelin lowdosegallicacidadministrationdoesnotimprovedietinducedmetabolicdisordersandatherosclerosisinapoeknockoutmice AT xiangboan lowdosegallicacidadministrationdoesnotimprovedietinducedmetabolicdisordersandatherosclerosisinapoeknockoutmice AT shuangliu lowdosegallicacidadministrationdoesnotimprovedietinducedmetabolicdisordersandatherosclerosisinapoeknockoutmice AT yaowang lowdosegallicacidadministrationdoesnotimprovedietinducedmetabolicdisordersandatherosclerosisinapoeknockoutmice AT yunpengxie lowdosegallicacidadministrationdoesnotimprovedietinducedmetabolicdisordersandatherosclerosisinapoeknockoutmice AT jiaweiliao lowdosegallicacidadministrationdoesnotimprovedietinducedmetabolicdisordersandatherosclerosisinapoeknockoutmice |